Cognitive Training for Emotion Regulation in Psychotic Disorders
Launched by UNIVERSITY OF GEORGIA · May 29, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a special kind of training, called cognitive training, can help people with schizophrenia or schizoaffective disorder better manage their emotions. The researchers believe that this training might improve brain activity in a specific area that controls emotions, leading to better emotional regulation. The study is currently recruiting participants who are between 18 and 60 years old, speak English, and have been diagnosed with one of these disorders. It's important that participants are stable in their treatment, meaning their medication hasn't changed in the last month.
If you or someone you know is interested in participating, you'll need to meet certain criteria, like having a pre-existing level of intelligence above a certain point and not having any significant history of brain injury or substance abuse. Participants can expect to take part in activities that are designed to help improve emotional control, and they will receive support throughout the process. This study could offer valuable insights into new ways to help manage emotions for those living with these conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • diagnostic and statistical manual fifth edition diagnosis of schizophrenia or schizoaffective disorder
- • 18-60 years old
- • speaks English
- • premorbid intelligence quotient \> 70
- • clinically stable as indicated by no antipsychotic medication changes in the last month or if on depot, no change in the past 2 months.
- Exclusion Criteria:
- • history of intellectual disability or neurological disorder
- • history of traumatic brain injury with loss of consciousness \> 10 minutes or behavioral sequelae
- • substance use disorder within the last 6 months (other than nicotine)
- • 4) endorsement of MRI exclusion factors
About University Of Georgia
The University of Georgia (UGA) is a leading research institution dedicated to advancing scientific knowledge and improving public health through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, UGA leverages its extensive resources and expertise in various fields, including medicine, pharmacy, and public health, to conduct rigorous and impactful research. The university is committed to ethical standards and participant safety, ensuring that all clinical trials are designed to generate reliable data that can inform clinical practice and policy. UGA's focus on education and community engagement further enhances its role as a vital contributor to the advancement of healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Athens, Georgia, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials